Trump signs order to accelerate access to psychedelic drug treatments
WASHINGTON, April 18 – In a move that signals a notable shift in federal health policy, U.S. President Donald Trump signed an executive order on Saturday aimed at accelerating research and access to treatments derived from psychedelic substances. The directive focuses particularly on ibogaine, a compound that has drawn growing attention for its potential role … Read more